A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
about
LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidenceCrystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18.Modulation of Toll-like receptor activity by leukocyte Ig-like receptors and their effects during bacterial infectionThe MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytesIdentification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cellsHuman cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicityRegulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interactionIg-like transcript 4 inhibits lipid antigen presentation through direct CD1d interactionStructural basis for NKG2A/CD94 recognition of HLA-E.Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7Multiple receptors for HLA-G on human natural killer cellsIdentification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cellsA novel member of the leukocyte receptor complex regulates osteoclast differentiationPlasticity in the organization and sequences of human KIR/ILT gene familiesTetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cellsHuman inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-GExpression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cellsLeukocyte Ig-Like Receptors - A Model for MHC Class I Disease AssociationsFc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseasesHuman cytomegalovirus and autoimmune diseaseThe CD200-CD200R1 inhibitory signaling pathway: immune regulation and host-pathogen interactionsMolecular Recognition of Paired Receptors in the Immune SystemCrystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptorCellular Expression and Crystal Structure of the Murine Cytomegalovirus Major Histocompatibility Complex Class I-like Glycoprotein, m153Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptorCrystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k): A MYELOID INHIBITORY RECEPTOR INVOLVED IN IMMUNE TOLERANCECrystal structures of the two membrane-proximal Ig-like domains (D3D4) of LILRB1/B2: alternative models for their involvement in peptide-HLA bindingStructural basis for simultaneous recognition of an O-glycan and its attached peptide of mucin family by immune receptor PILRTargeting of a natural killer cell receptor family by a viral immunoevasinMolecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptorsIsotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complexInhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-BDifferential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomasLymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathwayCo-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan AfricansActivation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptorDAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinaseCharacterisation of bovine leukocyte Ig-like receptorsLILRA2 selectively modulates LPS-mediated cytokine production and inhibits phagocytosis by monocytes
P2860
Q21091044-39BAF4C3-71E3-4864-BCB8-816CE21FBC31Q21256433-7936819E-D421-4483-9CB0-E14C3C2DAC27Q21296861-F10BD6CD-1E32-4CB6-93E7-F8AB4D0656DAQ22008474-DDA4383D-9486-4348-954F-3559CBDD01E0Q22010576-DB8795D3-3EFD-4884-A83E-3D390CDCA555Q24303742-D297565D-C5B3-4D54-A69B-A9823C5D54B5Q24309134-0B76CA41-B60F-4E40-90FE-444022B947B3Q24313634-4667A19C-A1E6-45D5-8771-5EC9A61F5192Q24336854-F972974C-A6EE-4DCA-B01D-9A5990811F99Q24597517-B1D76639-49E5-4770-8E7D-3F8F108E664AQ24645618-25BAEB2A-6BBF-42B2-8BE7-C62ED488346BQ24671834-13D7666C-D459-4071-A1A6-F5F25139BA1BQ24675157-52B26B0A-5D01-4A6B-B30F-FADD15F143BBQ24676718-7E956135-6C01-413D-BD68-ED4B8375D5F3Q24676756-7DB0D46A-4571-4C71-9959-5C576B9E4499Q24678795-9388E41D-35FC-4519-A11F-9E18F891C7E0Q24793218-4119F2BB-1B45-42EF-82B9-DB585440932DQ26738439-DBE4799A-59EF-4BA4-833B-D59AAABE6439Q26783175-45597473-DD29-4CD3-BE81-7A65E6E7C9ACQ26850549-5526AF61-0660-40A8-8A7E-0B2342825EC3Q27005990-81D53489-1B5C-4288-80E8-E94C6AF766B5Q27500369-62793FAE-C969-49F2-81EE-2FE72247CB7FQ27641776-9AFF5494-9FB8-4F14-8A92-595493D4A4CAQ27648567-C895030E-5A63-475B-867E-AF3C183D1213Q27651216-606A5611-98FE-4000-8C5F-66FEB0D59353Q27667381-08BD547A-A465-4E39-8B45-7A14B2945B71Q27679716-8D5B7102-C3AB-4030-A359-14D72826E573Q27684050-F928548B-7934-48C0-87BD-666F40071A60Q27684601-BB63D80A-3DCC-4406-A8C1-47E59ED70689Q28137748-23464747-B605-49F7-99BD-EFBA7264A962Q28199758-82CFD91A-3D41-4264-A26B-E603CC85D1ECQ28292134-781EFFF6-F54E-4935-BE1B-E56D100508C0Q28360737-CEC93C5F-0567-43EA-AE05-B31C7919FAC3Q28364322-BE3FDF1A-9665-4993-9FA4-758E21BFF430Q28476661-F515E928-D118-44EC-853D-FCDDB65BD624Q28534758-B5C292B3-B2C7-4DC6-9358-4BA3CC5A1E73Q28588971-7CE42D91-C184-41DA-A80A-B8BA3DDCFD4CQ28610866-40B02A1E-8EB4-4FE4-838F-16C952688FBFQ28730806-23869BAB-96BB-46D4-9B0D-A4923D2C14F8Q28730830-CCF2FFB4-0BBD-47B5-812B-9432064BAEC0
P2860
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
@ast
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
@en
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
@en-gb
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
@nl
type
label
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
@ast
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
@en
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
@en-gb
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
@nl
prefLabel
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
@ast
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
@en
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
@en-gb
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
@nl
P2093
P921
P3181
P1433
P1476
A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
@en
P2093
L Peterson
P304
P3181
P356
10.1016/S1074-7613(00)80529-4
P407
P577
1997-08-01T00:00:00Z